NUEVOS COMPUESTOS INHIBIDORES DE LA FOSFODIESTERASA DEL TIPO 10A
Compuestos de la fórmula I, Donde R1, R2, R3, R4 y R5 se definen en las reivindicaciones y X es C-R6 o N, Y es CR7 o N, donde R6 y R7 son, entre otros, hidrógeno, halógeno, alcoxi, haloalcoxi y semejantes. The compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
31.03.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compuestos de la fórmula I, Donde R1, R2, R3, R4 y R5 se definen en las reivindicaciones y X es C-R6 o N, Y es CR7 o N, donde R6 y R7 son, entre otros, hidrógeno, halógeno, alcoxi, haloalcoxi y semejantes.
The compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders. |
---|---|
Bibliography: | Application Number: UY20130034980 |